Science Sun Pharm announced that the company recently received a notice of compliance inspection for drug GMP issued by the Beijing Drug Administration. The inspection scope includes the small-volume injection production workshop X4 line, thin mushroom peptide injection, etc. The inspection period is from January 21 to January 24, 2025, with the conclusion being compliance with the "Good Manufacturing Practice for Pharmaceutical Products" and appendix requirements. This inspection is beneficial for improving the company's product structure and enhancing production capacity, which has a positive driving effect on the company's future steady development